// App-Quantinova.ai

3799 : The PAK4 allosteric modulator (KPT-9274) attenuates the growth of renal cell carcinoma

Researchers

Presenter

  • Robert H. Weiss

Principal Investigators

  • Omran Abu Aboud

  • Erkan Baloglu

  • William Senapedis

  • Sharon Shacham

Medical Centers

  • UC Davis, Davis, CA.

  • Karyopharm, Newton, MA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Renal cell carcinoma

  • Metastatic Renal Cell Cancer

  • Solid malignancies

  • Potassium aggravated myotonia

Biomarkers

  • cMYC

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved